Black Hawk Acquisition holds extraordinary general meeting; 77.3% of shares represented
BKHA•Black Hawk Acquisition Corporation held an extraordinary general meeting on October 13, 2026, with 77.3% of shares represented. Shareholders approved the business combination agreement with Vesicor Therapeutics and related proposals, including a Delaware domestication and selection of five directors.
1. Shareholders approve proposals
Shareholders authorized the business combination agreement with Vesicor Therapeutics and BH Merger Sub, covering the related transactions. They also approved a Delaware domestication, a new certificate of incorporation and bylaws effective upon domestication, and five directors to serve after the business combination.
